Advances in determination of vitamin D related compounds in biological samples using liquid chromatography-mass spectrometry: a review.

[1]  J. Haddad,et al.  COMPETITIVE PROTEIN-BINDING RADIOASSAY FOR 25-HYDROXYCHOLECALCIFEROL1 , 1971 .

[2]  Michael R. Green,et al.  The oxidation of a low-spin macrocyclic cobalt(II) Schiff-base complex , 1975 .

[3]  A. D. De leenheer,et al.  Vitamin D3 in plasma: quantitation by mass fragmentography. , 1978, Analytical biochemistry.

[4]  I. Björkhem,et al.  Mass fragmentographic assay of 25-hydroxyvitamin D3. , 1980, Methods in enzymology.

[5]  H. Sakagami,et al.  Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[6]  H. DeLuca,et al.  Vitamin D: recent advances. , 1983, Annual review of biochemistry.

[7]  H. DeLuca The vitamin D story: a collaborative effort of basic science and clinical medicine 1 , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  M. J. Varley,et al.  Measurement of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, 24,25-dihydroxyvitamin D2 and 25,26-dihydroxyvitamin D2 in a single plasma sample by mass fragmentography. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[9]  B. Hollis,et al.  Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. , 1993, Clinical chemistry.

[10]  C. Burtis Tietz textbook of Clinical Chemistry , 1994 .

[11]  K. Shimada,et al.  Determination of 25-hydroxyvitamin D3 in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[12]  C. Lind,et al.  Enzyme immunoassay for measuring 25-hydroxyvitamin D3 in serum. , 1997, Clinical chemistry.

[13]  N. Kobayashi,et al.  A Selective Immunoaffinity Chromatography for Determination of Plasma 1α,25-Dihydroxyvitamin D3: Application of Specific Antibodies Raised against a 1α,25-Dihydroxyvitamin D3–Bovine Serum Albumin Conjugate Linked through the 11α-Position , 1997 .

[14]  K. Kumaki,et al.  Determination of 22-oxacalcitriol, a new analog of 1alpha,25-dihydroxyvitamin D3, in human serum by liquid chromatography-mass spectrometry. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[15]  T. Higashi,et al.  New metabolic pathway of (24R)-24,25-dihydroxyvitamin D3: epimerization of the 3-hydroxy group. , 1999, Biological & pharmaceutical bulletin.

[16]  T. Higashi,et al.  Levels of 24,25-Dihydroxyvitamin D3, 25-Hydroxyvitamin D3 and 25-Hydroxyvitamin D3 3-Sulphate in Human Plasma , 1999, Annals of clinical biochemistry.

[17]  E. Ogata,et al.  The Advantage of Alfacalcidol Over Vitamin D in the Treatment of Osteoporosis , 1999, Calcified Tissue International.

[18]  M. Uskoković,et al.  1α,25‐Dihydroxy‐3‐epi‐vitamin D3: In vivo metabolite of 1α,25‐dihydroxyvitamin D3 in rats , 1999 .

[19]  Elina Hyppönen,et al.  Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.

[20]  T. Higashi,et al.  Determination of 24,25-dihydroxyvitamin D(3) in human plasma using liquid chromatography-mass spectrometry after derivatization with a Cookson-type reagent. , 2001, Biomedical chromatography : BMC.

[21]  A. Kissmeyer,et al.  Sensitive analysis of 1α,25-dihydroxyvitamin D3 in biological fluids by liquid chromatography–tandem mass spectrometry , 2001 .

[22]  B. Boyan,et al.  24,25-(OH)2D3 regulates cartilage and bone via autocrine and endocrine mechanisms , 2001, Steroids.

[23]  B. Boyan,et al.  Differential regulation of growth plate chondrocytes by 1alpha,25-(OH)2D3 and 24R,25-(OH)2D3 involves cell-maturation-specific membrane-receptor-activated phospholipid metabolism. , 2002, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[24]  B. Boyan,et al.  1α,25-Dihydroxyvitamin D3 and 24R,25-Dihydroxyvitamin D3 Modulate Growth Plate Chondrocyte Physiology via Protein Kinase C-Dependent Phosphorylation of Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinase. , 2002, Endocrinology.

[25]  T. Higashi,et al.  Liquid chromatography–mass spectrometric method combined with derivatization for determination of 1α-hydroxyvitamin D3 in human plasma , 2002 .

[26]  U. Stenman,et al.  Determination of 25-hydroxyvitamin D in serum by HPLC and immunoassay. , 2003, Clinical chemistry.

[27]  J. Gallagher,et al.  Effect of Vitamins D2 and D3 Supplement Use on Serum 25OHD Concentration in Elderly Women in Summer and Winter , 2004, Calcified Tissue International.

[28]  T. Higashi,et al.  Application of 4-(4-Nitrophenyl)-1,2,4-triazoline-3,5-dione to Analysis of 25- Hydroxyvitamin D3 in Human Plasma by Liquid Chromatography/Electron Capture Atmospheric Pressure Chemical Ionization-Mass Spectrometry , 2003, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[29]  R. Yolken,et al.  Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera , 2003, Schizophrenia Research.

[30]  T. Higashi,et al.  Analysis of C-3 epimerization in (24R)-24,25-dihydroxyvitamin D3 catalyzed by hydroxysteroid dehydrogenase. , 2004, Journal of pharmaceutical and biomedical analysis.

[31]  Glenville Jones,et al.  Insights into Vitamin D metabolism using cyp24 over-expression and knockout systems in conjunction with liquid chromatography/mass spectrometry (LC/MS) , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[32]  K. Inouye,et al.  C-3 Epimerization of Vitamin D3 Metabolites and Further Metabolism of C-3 Epimers , 2004, Journal of Biological Chemistry.

[33]  M. Vogeser,et al.  Candidate reference method for the quantification of circulating 25-hydroxyvitamin D3 by liquid chromatography-tandem mass spectrometry. , 2004, Clinical chemistry.

[34]  Glenville Jones,et al.  Enzymes involved in the activation and inactivation of vitamin D. , 2004, Trends in biochemical sciences.

[35]  D. Rao,et al.  Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. , 2004, Clinical biochemistry.

[36]  Ericka Stricklin-Parker,et al.  Ann , 2005 .

[37]  N. Tsugawa,et al.  Determination of 25-hydroxyvitamin D in human plasma using high-performance liquid chromatography--tandem mass spectrometry. , 2005, Analytical chemistry.

[38]  T. Kawanishi,et al.  The determination of 2β-(3-hydroxypropoxy)-1α,25-dihydroxy vitamin D3 (ED-71) in human serum by high-performance liquid chromatography–electrospray tandem mass spectrometry , 2005 .

[39]  S. Rainbow,et al.  Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. , 2005, Clinical chemistry.

[40]  Y. Aso,et al.  Ferrocene-based Diels-Alder derivatization for the determination of 1alpha-hydroxyvitamin D3 in rat plasma by high-performance liquid chromatography-electrospray tandem mass spectrometry. , 2005, Analytical biochemistry.

[41]  M. Drezner,et al.  HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. , 2006, Clinical chemistry.

[42]  A. Saenger,et al.  Quantification of serum 25-hydroxyvitamin D(2) and D(3) using HPLC-tandem mass spectrometry and examination of reference intervals for diagnosis of vitamin D deficiency. , 2006, American journal of clinical pathology.

[43]  T. Higashi Trace determination of steroids causing age-related diseases using LC/MS combined with detection-oriented derivatization. , 2006, Chemical & pharmaceutical bulletin.

[44]  Ravinder J. Singh,et al.  C-3 Epimers Can Account for a Significant Proportion of Total Circulating 25-hydroxyvitamin D in Infants, Complicating Accurate Measurement and Interpretation of Vitamin D Status , 2022 .

[45]  N. Kubodera Search for and Development of Active Vitamin D3 Analogs , 2006 .

[46]  R. Mehta,et al.  Hepatic activation and inactivation of clinically-relevant vitamin D analogs and prodrugs. , 2006, Anticancer research.

[47]  G. Carter,et al.  The anomalous behaviour of exogenous 25-hydroxyvitamin D in competitive binding assays , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[48]  B. Hollis,et al.  The assessment of circulating 25(OH)D and 1,25(OH)2D: Where we are and where we are going , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[49]  H. Weber,et al.  Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography–tandem mass spectrometry as a reference , 2008, Annals of clinical biochemistry.

[50]  B. Hammock,et al.  Metabolic profiling of major vitamin D metabolites using Diels–Alder derivatization and ultra-performance liquid chromatography–tandem mass spectrometry , 2008, Analytical and bioanalytical chemistry.

[51]  T. Higashi,et al.  Liquid chromatography–tandem mass spectrometric method for the determination of salivary 25-hydroxyvitamin D3: a noninvasive tool for the assessment of vitamin D status , 2008, Analytical and bioanalytical chemistry.

[52]  U. Turpeinen,et al.  Automated measurement of 25-OH vitamin D3 on the Roche Modular E170 analyzer. , 2008, Clinical chemistry.

[53]  S. Booth,et al.  Vitamin D3 in fat tissue , 2008, Endocrine.

[54]  Alex J. Brown,et al.  Vitamin D analogs: therapeutic applications and mechanisms for selectivity. , 2008, Molecular aspects of medicine.

[55]  M. Gröschl Current status of salivary hormone analysis. , 2008, Clinical chemistry.

[56]  B. Hollis Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D , 2008, Current opinion in endocrinology, diabetes, and obesity.

[57]  C. Pfeiffer,et al.  Measurement of 25-hydroxyvitamin D3 (25OHD3) and 25-hydroxyvitamin D2 (25OHD2) in human serum using liquid chromatography-tandem mass spectrometry and its comparison to a radioimmunoassay method. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[58]  N. Srinivas,et al.  Measurement of xenobiotics in saliva: is saliva an attractive alternative matrix? Case studies and analytical perspectives. , 2009, Biomedical chromatography : BMC.

[59]  K. Yasuda,et al.  Metabolism of 1alpha,25-dihydroxyvitamin D2 by human CYP24A1. , 2009, Biochemical and biophysical research communications.

[60]  A. Wallace,et al.  A simple automated solid-phase extraction procedure for measurement of 25-hydroxyvitamin D3 and D2 by liquid chromatography-tandem mass spectrometry , 2009, Annals of clinical biochemistry.

[61]  P. Mortensen,et al.  A sensitive LC/MS/MS assay of 25OH vitamin D3 and 25OH vitamin D2 in dried blood spots. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[62]  G. Carter,et al.  Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D , 2009, Annals of clinical biochemistry.